Vascular endothelial growth factor receptor 2 (VEGFR2) is implicated in CSCs that can trigger blebbishield emergency program-mediated sphere formation in RT4 (transitional cell papilloma) bladder cancer cells [63]. This evidence concerns the gene KDR and transitional cell papilloma.